Negative effect of parecoxib on bone mineral during fracture healing in rats

Acta Orthopaedica

Volumn 79, Issue 3, 2008, Pages 438-444

  Dimmen, Sigbjørn ^a,b   Nordsletten, Lars ^a,b   Engebretsen, Lars ^a   Steen, Harald ^b,c   Madsen, Jan Erik ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PARECOXIB; SODIUM CHLORIDE; ISOXAZOLE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CALCULATION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE HEALING; INTRAMEDULLARY NAIL; NONHUMAN; POSTOPERATIVE PERIOD; RAT; STATISTICAL SIGNIFICANCE; TIBIA FRACTURE; TREATMENT DURATION; ANIMAL; MECHANICAL STRESS; METABOLISM; OSTEOSYNTHESIS; WISTAR RAT;

ANIMALS; BONE DENSITY; CYCLOOXYGENASE INHIBITORS; FEMALE; FRACTURE FIXATION, INTERNAL; FRACTURE HEALING; ISOXAZOLES; RATS; RATS, WISTAR; STRESS, MECHANICAL; TIBIAL FRACTURES;

EID: 47249133812     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670710015373     Document Type: Article

References (43)

1. Aspenberg P. Avoid cox inhibitors after skeletal surgery! Acta Orthop Scand 2002; 73 (5): 489-90.
2. Aspenberg P. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2004; 22 (3): 684; author reply 685.
3. Beck A, Krischak G, Sorg T, Augat P, Farker K, Merkel U, Kinzl L, Claes L. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003; 123 (7): 327-32.
4. Bergenstock M, Min W, Simon A M, Sabatino C, O'Connor J P. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. J Orthop Trauma 2005; 19 (10): 717-23.
5. Brown K M, Saunders M M, Kirsch T, Donahue H J, Reid J S. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg (Am) 2004; 86 (1): 116-23.
6. Dahl V, Dybvik T, Steen T, Aune A K, Rosenlund E K, Raeder J C. Ibuprofen vs. acetaminophen vs. ibuprofen and acetaminophen after arthroscopically assisted anterior cruciate ligament reconstruction. Eur J Anaesthesiol 2004; 21 (6): 471-5.
7. Dahners L E, Mullis B H. Effects of nonsteroidal antiinflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 2004; 12 (3): 139-43.
8. Desjardins P J, Grossman E H, Kuss M E, Talwalker S, Dhadda S, Baum D, Hubbard R C. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 2001; 93 (3): 721-7.
9. Dubois R N, Abramson S B, Crofford L, Gupta R A, Simon L S, Van De Putte L B, Lipsky P E. Cyclooxygenase in biology and disease. Faseb J 1998; 12 (12): 1063-73.
10. Einhorn T A. Do inhibitors of cyclooxygenase-2 impair bone healing? J Bone Miner Res 2002; 17 (6): 977-8.
11. Ekeland A, Engesaeter L B, Langeland N. Mechanical properties of fractured and intact rat femora evaluated by bending, torsional and tensile tests. Acta Orthop Scand 1981; 52 (6): 605-13.
12. Endo K, Sairyo K, Komatsubara S, Sasa T, Egawa H, Ogawa T, Yonekura D, Murakami R, Yasui N. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop 2005; 76 (4): 470-4.
13. Engesaeter L B, Sudmann B, Sudmann E. Fracture healing in rats inhibited by locally administered indomethacin. Acta Orthop Scand 1992; 63 (3): 330-3.
14. Fogarty D J, O'Hanlon J J, Milligan K R. Intramuscular ketorolac following total hip replacement with spinal anaesthesia and intrathecal morphine. Acta Anaesthesiol Scand 1995; 39 (2): 191-4.
15. Gan T J, Joshi G P, Viscusi E, Cheung R Y, Dodge W, Fort J G, Chen C. Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery. Anesth Analg 2004; 98 (6): 1665-73, table of contents.
16. Gerstenfeld L C, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn T A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003; 21 (4): 670-5.
17. Gerstenfeld L C, Al-Ghawas M, Alkhiary Y M, Cullinane D M, Krall E A, Fitch J L, Webb E G, Thiede M A, Einhorn T A. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg (Am) 2007; 89 (1): 114-25.
18. Gillies G W, Kenny G N, Bullingham R E, McArdle C S. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987; 42 (7): 727-31.
19. Halpin R A, Geer L A, Zhang K E, Marks T M, Dean D C, Jones A N, Melillo D, Doss G, Vyas K P. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Drug Metab Dispos 2000; 28 (10): 1244-54.
20. Hogevold H E, Grogaard B, Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 1992; 63 (6): 607-11.
21. Hubbard R C, Naumann T M, Traylor L, Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 2003; 90 (2): 166-72.
22. Huntjens D R, Danhof M, Della Pasqua O E. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Rheumatology (Oxford) 2005; 44 (7): 846-59.
23. Keller J, Bayer-Kristensen I, Bak B, Bunger C, Kjaersgaard-Andersen P, Lucht U, Melsen F. Indomethacin and bone remodeling. Effect on cortical bone after osteotomy in rabbits. Acta Orthop Scand 1989; 60 (1): 119-21.
24. Kranke P, Morin A M, Roewer N, Eberhart L H. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg 2004; 99 (3): 797-806, table of contents.
25. Leese P T, Hubbard R C, Karim A, Isakson P C, Yu S S, Geis G S. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40 (2): 124-32.
26. Madsen J E, Hukkanen M, Aune A K, Basran I, Moller J F, Polak J M, Nordsletten L. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop 1998; (351): 230-40.
27. Malan T P, Jr., Marsh G, Hakki S I, Grossman E, Traylor L, Hubbard R C. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology 2003; 98 (4): 950-6.
28. McLoughlin C, McKinney M S, Fee J P, Boules Z. Diclofenac for day-care arthroscopy surgery: comparison with a standard opioid therapy. Br J Anaesth 1990; 65 (5): 620-3.
29. Meunier A, Aspenberg P. Parecoxib impairs early metaphyseal bone healing in rats. Arch Orthop Trauma Surg 2006; 126 (7): 433-6.
30. Mullis B H, Copland S T, Weinhold P S, Miclau T, Lester G E, Bos G D. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury 2006; 37 (9): 827-37.
31. Nordsletten L, Skjeldal S, Kirkeby O J, Ekeland A. Muscle contraction increases the strength of healing tibial fracture in the rat. Acta Orthop Scand 1994; 65 (2): 191-4.
32. Okada Y, Lorenzo J A, Freeman A M, Tomita M, Morham S G, Raisz L G, Pilbeam C C. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 2000; 105 (6): 823-32.
33. Paulson S K, Zhang J Y, Breau A P, Hribar J D, Liu N W, Jessen S M, Lawal Y M, Cogburn J N, Gresk C J, Markos C S, Maziasz T J, Schoenhard G L, Burton E G. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Drug Metab Dispos 2000; 28 (5): 514-21.
34. Rasmussen G L, Steckner K, Hogue C, Torri S, Hubbard R C. Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. Am J Orthop 2002; 31 (6): 336-43.
35. Rø J, Sudmann E, Marton P F. Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 1976; 47 (6): 588-99.
36. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A 1994; 91 (25): 12013-7.
37. Simon A M, Manigrasso M B, O'Connor J P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17 (6): 963-76.
38. Simon A M, O'Connor J P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg (Am) 2007; 89 (3): 500-11.
39. Stichtenoth D O, Frolich J C. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs 2003; 63 (1): 33-45.
40. Sudmann E, Dregelid E, Bessesen A, Morland J. Inhibition of fracture healing by indomethacin in rats. Eur J Clin Invest 1979; 9 (5): 333-9.
41. Talley J J, Bertenshaw S R, Brown D L, Carter J S, Graneto M J, Kellogg M S, Koboldt C M, Yuan J, Zhang Y Y, Seibert K. N-[[(5-methyl-3-phenylisoxazol-4- yl)-pheny l]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration. J Med Chem 2000; 43 (9): 1661-3.
42. Weber E W, Slappendel R, Durieux M E, Dirksen R, van der Heide H, Spruit M. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 2003; 20 (12): 963-6.
43. Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109 (11): 1405-15.